Clinical Trial Update: Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

An update on a Phase 4 clinical trial evaluating intraluminal clarithromycin powder as monotherapy for Helicobacter pylori infection; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

Sponsor: Mackay Memorial Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED